Thomson Reuters has introduced Thomson Reuters Cortellis, a drug research and development data solution for the life sciences industry.
Subscribe to our email newsletter
The system, which features latest information management technology, is said to help pharma professionals access and use data across the entire drug research and development life cycle, Reuters reported.
Thomson Reuters Cortellis will help companies to access data hosted within Cortellis and merge it with their own data, or with public data sources.
Through the technology, customers can access through an API (application programming interface), and a Software Development Toolkit, to build tailored applications that meet the specific needs of their end-users.
In addition, the solution equipped with TIBCO Spotfire visualization and analysis tools, provides update on the global drug pipeline, deal information, patent filings, besides industry news and conference coverage.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.